Preclinical
Products and Services
Before a drug can be marketed, its efficacy, safety, and mechanism of action must undergo a comprehensive evaluation. Aniphe BioLab has long been dedicated to the field of laboratory animals and animal‑based research services, striving to provide global innovative pharmaceutical companies and research institutions with a full‑range, high‑quality, integrated preclinical solution.
Leveraging a dedicated team of experts and an extensive array of animal resources, Aniphe BioLabtechnology has established a comprehensive suite of human disease models spanning key research areas such as oncology, neuroscience, and metabolism. From challenging models like cerebral ischemia–reperfusion (MCAO/R), myocardial infarction/myocardial ischemia (MI), and transverse aortic constriction (TAC), to neurological and metabolic models including spinal cord injury (SCI), epilepsy, and Alzheimer’s disease (AD), as well as cell‑derived xenograft tumor models (CDX) and patient‑derived xenograft tumor models (PDX) tailored for the era of precision medicine, Ailinfei consistently achieves high‑success‑rate, stable model generation. Coupled with a full complement of small‑animal behavioral assessment systems and cutting‑edge mouse imaging platforms, the company offers end‑to‑end in vivo pharmacology, toxicology, and pharmacodynamic evaluation services. This integrated, one‑stop technical solution empowers researchers to advance their projects efficiently, accelerating the transition from target discovery to Investigational New Drug (IND) application.
Sold laboratory animals
Customized animal models
Our Products and Services
Aniphe BioLab has established a comprehensive R&D, manufacturing, and sales process and management system. Guided by market demand and committed to the principles of pragmatism, truth-seeking, and mutual benefit, the company fosters innovation through industry–university–research collaboration, serving the fields of biological research and the new‑drug development industry, thereby contributing to human health and well-being.











Su Public Security Bureau Internet Information Service Filing No. 32010402001421